- Abzena History
We are proud of our 20+ years
of history moving medicine forward.
- Abzena Locations
We operate from state-of-the-art
facilities in the US and the UK.
- About Abzena
We are a leading complex biologics
and bioconjugates CDMO + CRO.
- Moving Medicine Forward
It's what we do. We take on complex
biologic & bioconjugate programs.
- Abzena History
Search results
Fusion Antibodies up 12% on cash runway relief
Proactive Financial News· 2 hours agoFusion Antibodies PLC (AIM:FAB) saw its shares rise by 12% after confirming it has a cash runway extending into the second quarter of 2025. Fusion,...
Global Geriatric Care Services Market is set for significant growth, expected to hit USD 954 million
PharmiWeb· 4 hours agoThe global geriatric care services market is experiencing a remarkable surge in demand, fueled by a projected Compound Annual Growth Rate (CAGR) of 6.0% from 2022 to 2032. By service, the adult ...
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
Zacks via Yahoo Finance UK· 16 hours agoCartesian (RNAC) announced that the phase IIb study in MG patients has achieved its primary...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News UK· 17 hours agoDonanemab’s effectiveness likely comes from its ability to specifically target the toxic plaques of...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance UK· 22 hours agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
The shock realities of babies with deadly virus as experts issue warning
The Irish Sun· 22 hours agoA PHARMACIST is campaigning for RSV immunisations for all babies this winter as experts warn of the...
FDA approves second Alzheimer’s drug that can modestly slow disease
Daily Echo· 23 hours agoThe Food and Drug Administration (FDA) approved Eli Lilly’s Kisunla, known chemically as donanemab, for mild or early cases of dementia caused by Alzheimer’s. It is only the second drug that ...
'Game-changing' Alzheimer's drug is approved in US - as UK decision imminent
The Sun· 1 day ago"We are hopeful that a decision will be made later this year for Great Britain." Donanemab, made by...
Vestibular hair cells are more prone to damage by excessive acceleration insult in the mouse with...
Nature· 1 day agoAll of the animal experimental procedures and a study enrolling humans were approved by the Yonsei University Health System Institutional Animal Care and Use Committee (approval No. 2016-0254 ...
AANAT1 regulates insect midgut detoxification through the ROS/CncC pathway - Communications Biology
Nature· 1 day agoArylalkylamine Nacetyltransferase 1 regulates the insect intestinal detoxification process through modulation of the reactive oxygen species-activated transcription factors pathway.
8.0/10 (1522 reviews)
